Suzhou-based CD Biopharma, a fast-growing biotech company in the clinical stage, has been approved by the FDA for its CD-001 Investigational New Drug (IND) application, marking the start of a phase I human trial...
AstraZeneca, a worldwide biopharmaceutical company focused on science, declared that FluMist is now the sole self-administered flu vaccine approved in the United States. FluMist, a nasal spray without needles, was authorized for...
Prime Minister Narendra Modi declared assistance of USD 7.5 million in sampling kits, detection kits, and vaccines for nations combatting cervical cancer. Addressing the Cancer Moonshot event in Delaware, Modi stressed India's dedication to...
InnoCare Pharma, a top biopharmaceutical company specializing in cancer and autoimmune disease treatments, declared the approval of the Investigational New Drug (IND) to carry out a clinical trial of ICP-248, a B-cell lymphoma-2 (BCL2) inhibitor...
Blockchain for Impact (BFI), a philanthropic organisation, has signed a Letter of Intent to collaborate with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India, marking a significant...
Leading pharmaceutical company Lupin Limited has revealed a non-exclusive patent license agreement with Takeda Pharmaceutical Company Limited to sell vonoprazan tablets in India. Lupin will be launching their new drug, Lupivon, in two different...
Zydus Lifesciences Ltd announced that it will acquire Sterling Biotech's 'Target Business', which is principally engaged in the manufacturing process of fermentation-based active pharmaceutical ingredients products, as well as a production facility..
The Organisation for Rare illnesses India (ORDI) and St John's Medical College and Hospital have signed a Memorandum of Understanding (MoU) to help children with rare kidney illnesses and their families. These include about 150 rare illnesses...
Max Healthcare has announced a strategic partnership with Lakshdeep Group to obtain a majority share in Jaypee Healthcare, which is currently in Corporate Insolvency Resolution Process (CIRP). The purchase is valued at Rs 1,660 crore in terms of...
Stealth BioTherapeutics Inc., a biotech company in clinical stage, and Friedreich’s Ataxia Research Alliance (FARA) have announced that Stealth has received the Kyle Bryant Translational Research Award from FARA to study SBT-589 in Friedreich’s...
.jpg)
, CDSCO.jpg)
.jpg)